{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:03:32Z","timestamp":1789142612065,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH113700"],"award-info":[{"award-number":["R01MH113700"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08102-0","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:56:00Z","timestamp":1776502560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ultra-high field magnetic resonance spectroscopy study of transcranial magnetic stimulation treatment in adolescents with depression"],"prefix":"10.1186","volume":"26","author":[{"given":"Cicek N.","family":"Bakir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Nakonezny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Azamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Shekunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L. Vande","family":"Voort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Marja\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Croarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"5","key":"8102_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJMra2033475","volume":"385","author":"L Miller","year":"2021","unstructured":"Miller L, Campo JV. Depression in Adolescents. N Engl J Med. 2021;385(5):445\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"8102_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62(1):63\u201377.","journal-title":"Neuropharmacology"},{"issue":"1","key":"8102_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","volume":"102","author":"RS Duman","year":"2019","unstructured":"Duman RS, Sanacora G, Krystal JH. Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments. Neuron. 2019;102(1):75\u201390.","journal-title":"Neuron"},{"issue":"1","key":"8102_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15374416.2015.1123637","volume":"45","author":"B Klimes-Dougan","year":"2016","unstructured":"Klimes-Dougan B, Garber J. Regulatory Control and Depression in Adolescents: Findings from Neuroimaging and Neuropsychological Research. J Clin Child Adolesc Psychol. 2016;45(1):1\u20135.","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"10","key":"8102_CR5","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.biopsych.2019.09.012","volume":"86","author":"TC Ho","year":"2019","unstructured":"Ho TC. Stress and Neurodevelopment in Adolescent Depression. Biol Psychiatry. 2019;86(10):e33\u20135.","journal-title":"Biol Psychiatry"},{"key":"8102_CR6","doi-asserted-by":"publisher","first-page":"119747","DOI":"10.1016\/j.jad.2025.119747","volume":"389","author":"H Zhou","year":"2025","unstructured":"Zhou H, Gao Y, Dong T, Wang J, Liu Z-F. Magnetic resonance spectroscopy studies in children and adolescents with depression: A systematic review and meta-analysis. J Affect Disord. 2025;389:119747.","journal-title":"J Affect Disord"},{"key":"8102_CR7","first-page":"650450","volume":"2011","author":"DG Kondo","year":"2011","unstructured":"Kondo DG, Hellem TL, Sung YH, Kim N, Jeong EK, Delmastro KK, et al. Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder. Depress Res Treat. 2011;2011:650450.","journal-title":"Depress Res Treat"},{"issue":"3","key":"8102_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11065-015-9295-8","volume":"25","author":"G Ende","year":"2015","unstructured":"Ende G. Proton Magnetic Resonance Spectroscopy: Relevance of Glutamate and GABA to Neuropsychology. Neuropsychol Rev. 2015;25(3):315\u201325.","journal-title":"Neuropsychol Rev"},{"key":"8102_CR9","doi-asserted-by":"publisher","first-page":"118500","DOI":"10.1016\/j.neuroimage.2021.118500","volume":"243","author":"S Verstraelen","year":"2021","unstructured":"Verstraelen S, Cuypers K, Maes C, Hehl M, Van Malderen S, Levin O, et al. Neurophysiological modulations in the (pre)motor-motor network underlying age-related increases in reaction time and the role of GABA levels - a bimodal TMS-MRS study. NeuroImage. 2021;243:118500.","journal-title":"NeuroImage"},{"issue":"4","key":"8102_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4329\/wjr.v3.i4.105","volume":"3","author":"MC Stephenson","year":"2011","unstructured":"Stephenson MC, Gunner F, Napolitano A, Greenhaff PL, Macdonald IA, Saeed N, et al. Applications of multi-nuclear magnetic resonance spectroscopy at 7T. World J Radiol. 2011;3(4):105\u201313.","journal-title":"World J Radiol"},{"key":"8102_CR11","doi-asserted-by":"crossref","unstructured":"Dobberthien BJ, Tessier AG, Yahya A. Improved resolution of glutamate, glutamine and \u03b3-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T. NMR Biomed. 2018;31(1).","DOI":"10.1002\/nbm.3851"},{"issue":"5","key":"8102_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/mrm.10146","volume":"47","author":"M Terpstra","year":"2002","unstructured":"Terpstra M, Ugurbil K, Gruetter R. Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla. Magn Reson Med. 2002;47(5):1009\u201312.","journal-title":"Magn Reson Med"},{"issue":"6","key":"8102_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J","volume":"11","author":"M Mescher","year":"1998","unstructured":"Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998;11(6):266\u201372.","journal-title":"NMR Biomed"},{"issue":"5","key":"8102_CR14","doi-asserted-by":"publisher","first-page":"e4199","DOI":"10.1002\/nbm.4199","volume":"34","author":"DK Deelchand","year":"2021","unstructured":"Deelchand DK, Marja\u0144ska M, Henry PG, Terpstra M. MEGA-PRESS of GABA+: Influences of acquisition parameters. NMR Biomed. 2021;34(5):e4199.","journal-title":"NMR Biomed"},{"issue":"3","key":"8102_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/mrm.1213","volume":"46","author":"I Tk\u00e1c","year":"2001","unstructured":"Tk\u00e1c I, Andersen P, Adriany G, Merkle H, Ugurbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med. 2001;46(3):451\u20136.","journal-title":"Magn Reson Med"},{"issue":"10","key":"8102_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","volume":"81","author":"MS Lener","year":"2017","unstructured":"Lener MS, Niciu MJ, Ballard ED, Park M, Park LT, Nugent AC, et al. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine. Biol Psychiatry. 2017;81(10):886\u201397.","journal-title":"Biol Psychiatry"},{"key":"8102_CR17","doi-asserted-by":"publisher","first-page":"637863","DOI":"10.3389\/fpsyt.2021.637863","volume":"12","author":"A Sarawagi","year":"2021","unstructured":"Sarawagi A, Soni ND, Patel AB. Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder. Front Psychiatry. 2021;12:637863.","journal-title":"Front Psychiatry"},{"issue":"1","key":"8102_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1503\/jpn.160228","volume":"43","author":"B Romeo","year":"2018","unstructured":"Romeo B, Choucha W, Fossati P, Rotge JY. Meta-analysis of central and peripheral \u03b3-aminobutyric acid levels in patients with unipolar and bipolar depression. J Psychiatry Neurosci. 2018;43(1):58\u201366.","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"8102_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mrm.26691","volume":"79","author":"M Gu","year":"2018","unstructured":"Gu M, Hurd R, Noeske R, Baltusis L, Hancock R, Sacchet MD, et al. GABA editing with macromolecule suppression using an improved MEGA-SPECIAL sequence. Magn Reson Med. 2018;79(1):41\u20137.","journal-title":"Magn Reson Med"},{"issue":"1","key":"8102_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neubiorev.2011.05.014","volume":"36","author":"JJ Luykx","year":"2012","unstructured":"Luykx JJ, Laban KG, van den Heuvel MP, Boks MP, Mandl RC, Kahn RS, et al. Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Neurosci Biobehav Rev. 2012;36(1):198\u2013205.","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"8102_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","volume":"61","author":"G Sanacora","year":"2004","unstructured":"Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry. 2004;61(7):705\u201313.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"8102_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-014-3687-y","volume":"232","author":"BR Godlewska","year":"2015","unstructured":"Godlewska BR, Near J, Cowen PJ. Neurochemistry of major depression: a study using magnetic resonance spectroscopy. Psychopharmacology. 2015;232(3):501\u20137.","journal-title":"Psychopharmacology"},{"issue":"12","key":"8102_CR23","first-page":"1049","volume":"4","author":"L Colic","year":"2019","unstructured":"Colic L, von D\u00fcring F, Denzel D, Demenescu LR, Lord AR, Martens L, et al. Rostral Anterior Cingulate Glutamine\/Glutamate Disbalance in Major Depressive Disorder Depends on Symptom Severity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(12):1049\u201358.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"9","key":"8102_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","volume":"68","author":"C Y\u00fcksel","year":"2010","unstructured":"Y\u00fcksel C, \u00d6ng\u00fcr D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry. 2010;68(9):785\u201394.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"8102_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/archgenpsychiatry.2011.131","volume":"69","author":"V Gabbay","year":"2012","unstructured":"Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, et al. Anterior cingulate cortex \u03b3-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry. 2012;69(2):139\u201349.","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"8102_CR26","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.4088\/JCP.13r08767","volume":"75","author":"AE Spencer","year":"2014","unstructured":"Spencer AE, Uchida M, Kenworthy T, Keary CJ, Biederman J. Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature. J Clin Psychiatry. 2014;75(11):1226\u201341.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"8102_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41398-020-0792-z","volume":"10","author":"CP Lewis","year":"2020","unstructured":"Lewis CP, Port JD, Blacker CJ, Sonmez AI, Seewoo BJ, Leffler JM, et al. Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation. Transl Psychiatry. 2020;10(1):119.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"8102_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1017\/S1461145710001094","volume":"14","author":"MJ Taylor","year":"2011","unstructured":"Taylor MJ, Mannie ZN, Norbury R, Near J, Cowen PJ. Elevated cortical glutamate in young people at increased familial risk of depression. Int J Neuropsychopharmacol. 2011;14(2):255\u20139.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8102_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pscychresns.2015.11.005","volume":"247","author":"PE Croarkin","year":"2016","unstructured":"Croarkin PE, Nakonezny PA, Wall CA, Murphy LL, Sampson SM, Frye MA, et al. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents. Psychiatry Res Neuroimaging. 2016;247:25\u201333.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"1","key":"8102_CR30","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41398-024-03186-2","volume":"14","author":"M Wada","year":"2024","unstructured":"Wada M, Nakajima S, Honda S, Takano M, Taniguchi K, Homma S, et al. Decreased prefrontal glutamatergic function is associated with a reduced astrocyte-related gene expression in treatment-resistant depression. Transl Psychiatry. 2024;14(1):478.","journal-title":"Transl Psychiatry"},{"key":"8102_CR31","doi-asserted-by":"crossref","unstructured":"Lewis CP, Nakonezny PA, Sonmez AI, Ozger C, Garzon JF, Camsari DD et al. A dose-finding, biomarker validation, and effectiveness study of transcranial magnetic stimulation for adolescents with depression. J Am Acad Child Adolesc Psychiatry. 2024.","DOI":"10.1016\/j.jaac.2024.08.487"},{"key":"8102_CR32","unstructured":"Adriany GYE, Tkac I, Andersen P, Merkle H, Vaughan JT, Ugurbil K. Shielded surface coils and halfvolume cavity resonators for imaging and spectroscopy applications at 7 Tesla2000:[563 p.]. Available from: https:\/\/cds.ismrm.org\/ismrm-2000\/PDF2\/0563.pdf."},{"key":"8102_CR33","doi-asserted-by":"publisher","first-page":"104940","DOI":"10.1016\/j.neubiorev.2022.104940","volume":"144","author":"D Pasanta","year":"2023","unstructured":"Pasanta D, He JL, Ford T, Oeltzschner G, Lythgoe DJ, Puts NA. Functional MRS studies of GABA and glutamate\/Glx - A systematic review and meta-analysis. Neurosci Biobehav Rev. 2023;144:104940.","journal-title":"Neurosci Biobehav Rev"},{"key":"8102_CR34","doi-asserted-by":"publisher","first-page":"119273","DOI":"10.1016\/j.neuroimage.2022.119273","volume":"257","author":"R Rideaux","year":"2022","unstructured":"Rideaux R, Ehrhardt SE, Wards Y, Filmer HL, Jin J, Deelchand DK, et al. On the relationship between GABA\u2009+\u2009and glutamate across the brain. NeuroImage. 2022;257:119273.","journal-title":"NeuroImage"},{"key":"8102_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/mrm.1213","volume":"46","author":"I Tk\u00e1c","year":"2001","unstructured":"Tk\u00e1c I, Andersen P, Adriany G, Merkle H, Ugurbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med. 2001;46:451\u20136.","journal-title":"Magn Reson Med"},{"issue":"2","key":"8102_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1","volume":"43","author":"R Gruetter","year":"2000","unstructured":"Gruetter R, Tk\u00e1c I. Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med. 2000;43(2):319\u201323.","journal-title":"Magn Reson Med"},{"issue":"4","key":"8102_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G","volume":"41","author":"I Tk\u00e1c","year":"1999","unstructured":"Tk\u00e1c I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med. 1999;41(4):649\u201356.","journal-title":"Magn Reson Med"},{"key":"8102_CR38","doi-asserted-by":"publisher","first-page":"120060","DOI":"10.1016\/j.neuroimage.2023.120060","volume":"272","author":"MP Schallmo","year":"2023","unstructured":"Schallmo MP, Weldon KB, Kamath RS, Moser HR, Montoya SA, Killebrew KW, et al. The psychosis human connectome project: Design and rationale for studies of visual neurophysiology. NeuroImage. 2023;272:120060.","journal-title":"NeuroImage"},{"issue":"6","key":"8102_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672\u20139.","journal-title":"Magn Reson Med"},{"key":"8102_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neuroscience.2017.04.035","volume":"354","author":"M Marja\u0144ska","year":"2017","unstructured":"Marja\u0144ska M, McCarten JR, Hodges J, Hemmy LS, Grant A, Deelchand DK, et al. Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using 1H magnetic resonance spectroscopy at 7 T. Neuroscience. 2017;354:168\u201377.","journal-title":"Neuroscience"},{"issue":"2","key":"8102_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/mrm.21122","volume":"57","author":"WD Rooney","year":"2007","unstructured":"Rooney WD, Johnson G, Li X, Cohen ER, Kim SG, Ugurbil K, et al. Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med. 2007;57(2):308\u201318.","journal-title":"Magn Reson Med"},{"issue":"4","key":"8102_CR42","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/mrm.10112","volume":"47","author":"R Bartha","year":"2002","unstructured":"Bartha R, Michaeli S, Merkle H, Adriany G, Andersen P, Chen W, et al. In vivo 1H2O T2\u2009+\u2009measurement in the human occipital lobe at 4T and 7T by Carr-Purcell MRI: detection of microscopic susceptibility contrast. Magn Reson Med. 2002;47(4):742\u201350.","journal-title":"Magn Reson Med"},{"key":"8102_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychires.2018.08.015","volume":"105","author":"KEM Godfrey","year":"2018","unstructured":"Godfrey KEM, Gardner AC, Kwon S, Chea W, Muthukumaraswamy SD. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis. J Psychiatr Res. 2018;105:33\u201344.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"8102_CR44","doi-asserted-by":"publisher","first-page":"e1216","DOI":"10.1038\/tp.2017.187","volume":"7","author":"V Gabbay","year":"2017","unstructured":"Gabbay V, Bradley KA, Mao X, Ostrover R, Kang G, Shungu DC. Anterior cingulate cortex \u03b3-aminobutyric acid deficits in youth with depression. Transl Psychiatry. 2017;7(8):e1216.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"8102_CR45","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","volume":"24","author":"S Moriguchi","year":"2019","unstructured":"Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2019;24(7):952\u201364.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"8102_CR46","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.biopsych.2006.08.048","volume":"61","author":"Z Bhagwagar","year":"2007","unstructured":"Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, et al. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry. 2007;61(6):806\u201312.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"8102_CR47","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","volume":"56","author":"G Sanacora","year":"1999","unstructured":"Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 1999;56(11):1043\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"8102_CR48","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1038\/s41380-021-01090-5","volume":"26","author":"XM Song","year":"2021","unstructured":"Song XM, Hu XW, Li Z, Gao Y, Ju X, Liu DY, et al. Reduction of higher-order occipital GABA and impaired visual perception in acute major depressive disorder. Mol Psychiatry. 2021;26(11):6747\u201355.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"8102_CR49","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1017\/S0033291717003373","volume":"48","author":"BR Godlewska","year":"2018","unstructured":"Godlewska BR, Masaki C, Sharpley AL, Cowen PJ, Emir UE. Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla. Psychol Med. 2018;48(10):1731\u20137.","journal-title":"Psychol Med"},{"key":"8102_CR50","doi-asserted-by":"publisher","first-page":"111238","DOI":"10.1016\/j.pscychresns.2020.111238","volume":"308","author":"V Truong","year":"2021","unstructured":"Truong V, Cheng PZ, Lee HC, Lane TJ, Hsu TY, Duncan NW. Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis. Psychiatry Res Neuroimaging. 2021;308:111238.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"1","key":"8102_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00221-002-1234-2","volume":"148","author":"HR Siebner","year":"2003","unstructured":"Siebner HR, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res. 2003;148(1):1\u201316.","journal-title":"Exp Brain Res"},{"key":"8102_CR52","doi-asserted-by":"crossref","unstructured":"McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, et al. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. J Clin Psychiatry. 2018;79(1).","DOI":"10.4088\/JCP.16cs10905"},{"key":"8102_CR53","doi-asserted-by":"publisher","first-page":"111455","DOI":"10.1016\/j.pnpbp.2025.111455","volume":"141","author":"K Godfrey","year":"2025","unstructured":"Godfrey K, Douglass H, Erritzoe D, Muthukumaraswamy S, Nutt D, Sumner R. The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2025;141:111455.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8102_CR54","doi-asserted-by":"publisher","first-page":"103049","DOI":"10.1016\/j.nicl.2022.103049","volume":"35","author":"MA Gonsalves","year":"2022","unstructured":"Gonsalves MA, White TL, Barredo J, Fukuda AM, Joyce HE, Harris AD, et al. Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review. Neuroimage Clin. 2022;35:103049.","journal-title":"Neuroimage Clin"},{"issue":"3","key":"8102_CR55","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/YCT.0000000000000094","volume":"30","author":"XR Yang","year":"2014","unstructured":"Yang XR, Kirton A, Wilkes TC, Pradhan S, Liu I, Jaworska N, et al. Glutamate alterations associated with transcranial magnetic stimulation in youth depression: a case series. J ect. 2014;30(3):242\u20137.","journal-title":"J ect"},{"key":"8102_CR56","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.neuroimage.2017.03.011","volume":"152","author":"K Dyke","year":"2017","unstructured":"Dyke K, P\u00e9p\u00e9s SE, Chen C, Kim S, Sigurdsson HP, Draper A, et al. Comparing GABA-dependent physiological measures of inhibition with proton magnetic resonance spectroscopy measurement of GABA using ultra-high-field MRI. NeuroImage. 2017;152:360\u201370.","journal-title":"NeuroImage"},{"key":"8102_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2020.11.011","volume":"452","author":"MC Ferland","year":"2021","unstructured":"Ferland MC, Therrien-Blanchet JM, Proulx S, Klees-Themens G, Bacon BA, Dang Vu TT, et al. Transcranial Magnetic Stimulation and H(1)-Magnetic Resonance Spectroscopy Measures of Excitation and Inhibition Following Lorazepam Administration. Neuroscience. 2021;452:235\u201346.","journal-title":"Neuroscience"},{"key":"8102_CR58","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jad.2015.10.020","volume":"190","author":"CP Lewis","year":"2016","unstructured":"Lewis CP, Nakonezny PA, Ameis SH, Vande Voort JL, Husain MM, Emslie GJ, et al. Cortical inhibitory and excitatory correlates of depression severity in children and adolescents. J Affect Disord. 2016;190:566\u201375.","journal-title":"J Affect Disord"},{"issue":"3","key":"8102_CR59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1600-079X.2003.00114.x","volume":"36","author":"TR Casta\u00f1eda","year":"2004","unstructured":"Casta\u00f1eda TR, de Prado BM, Prieto D, Mora F. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res. 2004;36(3):177\u201385.","journal-title":"J Pineal Res"},{"key":"8102_CR60","doi-asserted-by":"publisher","first-page":"110430","DOI":"10.1016\/j.jneumeth.2025.110430","volume":"418","author":"Y Song","year":"2025","unstructured":"Song Y, Prisciandaro JJ, Ap\u0161valka D, Bernard M, Berrington A, Castelo-Branco M, et al. Magnetic resonance spectroscopy and the menstrual cycle: A multi-centre assessment of menstrual cycle effects on GABA & GSH. J Neurosci Methods. 2025;418:110430.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"8102_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12993-024-00248-9","volume":"20","author":"H Li","year":"2024","unstructured":"Li H, Rodr\u00edguez-Nieto G, Chalavi S, Seer C, Mikkelsen M, Edden RAE, et al. MRS-assessed brain GABA modulation in response to task performance and learning. Behav Brain Funct. 2024;20(1):22.","journal-title":"Behav Brain Funct"},{"issue":"2","key":"8102_CR62","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.neuroimage.2009.09.007","volume":"49","author":"A Gussew","year":"2010","unstructured":"Gussew A, Rzanny R, Erdtel M, Scholle HC, Kaiser WA, Mentzel HJ, et al. Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation. NeuroImage. 2010;49(2):1895\u2013902.","journal-title":"NeuroImage"},{"issue":"12","key":"8102_CR63","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s00221-019-05691-z","volume":"237","author":"MC Ferland","year":"2019","unstructured":"Ferland MC, Therrien-Blanchet JM, Lefebvre G, Klees-Themens G, Proulx S, Th\u00e9oret H. Longitudinal assessment of (1)H-MRS (GABA and Glx) and TMS measures of cortical inhibition and facilitation in the sensorimotor cortex. Exp Brain Res. 2019;237(12):3461\u201374.","journal-title":"Exp Brain Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08102-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:04:43Z","timestamp":1780445083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08102-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8102"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08102-0","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in in accordance with the Declaration of Helsinki. The parent clinical trial was prospectively registered (NCT03363919). The research team obtained an investigational device exemption from the FDA (G170212). The study was reviewed and approved by the Mayo Clinic and University of Minnesota Institutional Review Boards before any research activities occurred. Prior to any research activities, parents or guardians provided informed consent for all participants aged 12\u201317 years and the adolescent participants provided informed assent. Participants aged 18 years of age provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Croarkin has received research support from the Agency for Healthcare Research and Quality (AHRQ), National Institutes of Health (NIH), National Science Foundation (NSF), Brain and Behavior Research Foundation, and the Mayo Clinic Foundation. Dr. Croarkin has received research support from Pfizer, Inc. He has received grant-in-kind equipment support from Neuronetics, Inc., and MagVenture, Inc. He received grant-in-kind supplies and genotyping from Assurex Health, Inc. for an investigator-initiated study. He served as the principal investigator for a multicenter study funded by Neuronetics, Inc. and a site principal investigator for studies funded by NeoSync, Inc. and Innosphere. Dr. Croarkin served as a paid consultant for Engrail Therapeutics, Meta Platforms, Inc, MindMed, Myriad Neuroscience, Procter & Gamble Company, and Sunovion. Dr. Croarkin is employed by Mayo Clinic. He receives compensation as the Editor-in-Chief for the Journal of Child and Adolescent Psychopharmacology. Dr. Vande Voort has received grant-in-kind supplies and genotyping from Assurex Health for an investigator-initiated study. The other authors have no disclosures to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}